Providers may choose a rabies PEP with the aid of the risk threshold.

Published Date: 13 Jun 2023

According to the authors, in 2017 and 2018, approximately 55,000 Americans annually received treatment for possible RABV exposure.

Read Full News

Latest News

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

News All Time

Socioeconomic Gaps Tied to Concussion-Related ED Visits

Socioeconomic disparities determine where patients seek concussion care and patients' likelihood of receiving follow-up care, a study finds.

Balanced Fluid: No Renal Benefit Over Saline in Septic Shock

In children with septic shock, choosing balanced fluid over saline does not appear to change short-term kidney outcomes or survival.

Is Telemedicine Comparable to In-Person Neurology Care?

Virtual neurology care for new patients is comparable to in-person care, with similar 90-day follow-up rates, ED visits, and hospitalizations, a new study shows.

Regenxbio Shares Sink as Safety Concerns Overshadow Muscle Disorder Therapy Trial Win

Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal ⁠in a late-stage study, but its shares plunged 31% in morning...

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

Drug overdose deaths in the United States fell nearly ⁠14% in 2025, federal estimates showed on Wednesday, marking a third ⁠consecutive year of declines.

Common Practice of DOAC Switching After Stroke Challenged

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants after a breakthrough ischemic stroke in patients with atrial fibrillation.

Resistant Gut Bacteria May Flag C difficile Infection Risk

Adults colonised with extended-spectrum beta-lactamase-producing bacteria in the intestinal tract may face higher odds of developing Clostridioides difficile infection.

High-Risk Mental Health Patients Left Unmonitored in A&E

A 3-year RCEM programme finds high-risk mental health patients in emergency departments are going unmonitored — though rates have improved significantly since 2023.

Scotland Clears New Bladder Cancer Combination Therapy

The Scottish Medicines Consortium has approved a new first-line combination therapy for restricted use in adults with unresectable or metastatic urothelial cancer.

Acute Extremity Pain in Patient With Cogan's Syndrome Signals Vascular Ischemia

Timely imaging, anticoagulation, and specialist consultations prevented loss of life or limb

Oregon Emergency Physicians Claim Win Against For-Profit Replacements

— Physicians sued their employer over plans to replace them with an out-of-state firm

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

HI-PEITHO Kicks Off 'Golden Era' in Pulmonary Embolism

Trial of ultrasound-based, catheter-directed thrombolysis is one of several anticipated studies

We Have a Substance Use Prevention Problem

Having kids hear from people with lived experience can help move the needle

Here's What People Want on 'The Pitt' Season 3

Attention writers on "The Pitt": our audience has suggestions

He Suddenly Couldn't Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

Doctors have ruled out a heart attack

Recommended News For You

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

Radioligand Therapy Set to Transform Oncology Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Women are more susceptible to the stress caused by inflation.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

Women who miss their first mammogram face higher risk of breast cancer death, study finds

Recommended Articles For You

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma 

Phosphate Vs. Phosphorus: What Is The Difference? 

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care

1.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

2.

Colon cancer: Risk factors, warning signs and treatment options 

3.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

4.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

5.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

3.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot